{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137043920176128.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.drudis.2011.04.001"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1359644611001073?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1359644611001073?httpAccept=text/plain"}}],"dc:title":[{"@value":"Targeting survivin in cancer: the cell-signalling perspective"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137043920176128","@type":"Researcher","foaf:name":[{"@value":"Jagat R. Kanwar"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137043920176130","@type":"Researcher","foaf:name":[{"@value":"Sishir K. Kamalapuram"}]},{"@id":"https://cir.nii.ac.jp/crid/1381137043920176129","@type":"Researcher","foaf:name":[{"@value":"Rupinder K. Kanwar"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13596446"}],"prism:publicationName":[{"@value":"Drug Discovery Today"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2011-06","prism:volume":"16","prism:number":"11-12","prism:startingPage":"485","prism:endingPage":"494"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1359644611001073?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1359644611001073?httpAccept=text/plain"}],"createdAt":"2011-04-18","modifiedAt":"2025-10-23","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360567184886520192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Upregulation of special AT-rich-binding protein 1 by Epstein–Barr virus latent membrane protein 1 in human nasopharyngeal cells and nasopharyngeal cancer"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.drudis.2011.04.001"},{"@type":"CROSSREF","@value":"10.1099/vir.0.046243-0_references_DOI_3u5MPRGQrxdonJAj3iehemYsKGD"}]}